RISK BASED INSPECTION [SCHEDULE M-POINT (34.14)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.14)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.14-768x1087.jpg)
In Risk-Based Inspection (RBI), Schedule M checklist point 34.14 is used to verify whether the Batch Packaging Record (BPR) is complete against global GMP expectations, i.e., it “covers all the points as prescribed in WHO TRS 986 & PIC” CDSCO…





![RISK BASED INSPECTION [SCHEDULE M-POINT (34.13)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.13-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.11-34.12)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.11-34.12-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.9-34.10)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.9-34.10-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (34.8)]](https://pharmadevils.com/wp-content/uploads/2024/11/WHO-TRS-986-34.8-1-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.7)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.7-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.5-34.6)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.5-34.6-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.4)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-34.4-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.3)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-34.3-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.1-34.2)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-34.1-34.2-768x1087.jpg)